03 · What You Need to Know
Sponsorship Is an Oversight Role With Defined Responsibilities
First, determine whether “sponsor” is a formally defined role in your research system
Research terminology is not universal. "Sponsor" has a formal governance or regulatory meaning in several health-research and clinical-trial frameworks, but the term may be used differently in other disciplines or institutions.
Under the current UK Policy Framework for Health and Social Care Research, the sponsor is the individual, organization, or partnership taking overall responsibility for proportionate and effective arrangements being in place to set up, run, and report the research project.
For clinical trials, ICH E6(R3) defines a sponsor as an individual, company, institution, or organization taking responsibility for the initiation, management, and arrangement of financing of a clinical trial. Applicable national or regional law can impose additional or more specific requirements.
Researchers should therefore identify the governing framework before transferring a definition from clinical trials into educational, social, laboratory, or other research where the same formal sponsorship structure may not apply.
The sponsor should examine whether the research is suitable to proceed
Sponsorship should not be a ceremonial signature applied after the research team has made every important decision.
The UK Policy Framework gives sponsors responsibility for identifying and addressing poorly designed or planned research and ensuring that research proposals and protocols are scientifically sound, safe, ethical, legal, and feasible and remain so during the project.
This does not mean the sponsor must personally design the methodology. Independent scientific review, investigator expertise, funding review, and ethics review may all contribute evidence. The sponsor's responsibility is to ensure that appropriate arrangements establish that the research is suitable to proceed.
The sponsor should ensure investigators and research sites are suitable
A protocol can be excellent and still fail if the people or sites expected to deliver it lack the necessary competence or resources.
The UK Policy Framework therefore assigns sponsors responsibility for satisfying themselves that investigators, research teams, and sites are suitable.
ICH E6(R3) similarly makes the clinical-trial sponsor responsible for selecting investigators and institutions and requires investigators to be appropriately qualified through education, training, and experience and to have adequate resources and facilities.
Suitability should be proportionate to the research. A low-risk interview project and a first-in-human clinical trial plainly require different levels of assurance.
The sponsor should ensure roles and responsibilities are clear
Research involving several organizations can fail through gaps between responsibilities rather than failure within any single role.
The sponsor should ensure that the responsibilities of parties involved in the research are agreed and appropriately documented. This becomes particularly important when sponsor activities are delegated, sites perform different functions, external service providers are used, or several institutions collaborate.
Clear documentation should answer practical questions such as who manages data, who reports safety information, who submits amendments, who monitors the study, who maintains essential records, and who communicates with sites or regulators where those functions apply.
This contributes to the broader question of how accountability is allocated across a research project.
The sponsor should ensure necessary approvals are in place
The sponsor is not necessarily the body granting ethics or regulatory approval. Its responsibility is different.
The UK Policy Framework assigns sponsors responsibility for ensuring that, where expected or required, research has approval from a research ethics committee and other relevant approval bodies before it begins. The sponsor must also verify that regulatory and practical arrangements are in place before permitting research to start.
ICH E6(R3) similarly requires sponsors, or sponsors together with investigators as applicable, to make required submissions to regulatory authorities and to ensure appropriate ethics-review documentation is obtained before clinical trials proceed.
This distinction helps explain why ethics approval may not itself be the final signal to start research. In systems with formal sponsorship, sponsor confirmation or other governance steps may still be required.
The sponsor should establish proportionate risk and quality management
Oversight should focus attention where failure would matter.
The UK Policy Framework requires sponsors to maintain appropriate arrangements for management of the project, including competent risk management and data management.
ICH E6(R3) goes further for clinical trials by embedding quality management throughout trial design and conduct. Sponsors should identify factors critical to trial quality, evaluate risks, implement proportionate controls, communicate relevant risks, review controls, and document important quality-management activities.
This is not an argument for maximizing monitoring. Modern research governance increasingly emphasizes proportionate oversight. A sponsor should distinguish critical risks from administrative trivia rather than treating every process deviation as equally consequential.
The sponsor should ensure appropriate monitoring and oversight
Research does not become self-governing once the first participant is enrolled.
The sponsor should establish processes for monitoring the research and responding to information that could affect participant safety, research integrity, compliance, or continued suitability of the protocol.
For clinical trials, ICH E6(R3) requires sponsor oversight of trial design and conduct, processes, and generated information and data so that trial results are reliable and participants are protected. Monitoring should be tailored to identified risks and can incorporate different methods depending on the study.
The purpose is not to duplicate the investigator's work. Investigator oversight and sponsor oversight operate at different governance levels.
The sponsor can delegate activities without making sponsorship disappear
Sponsors routinely use other organizations and specialists. Clinical trials may involve contract research organizations, monitoring providers, data-management companies, laboratories, statisticians, technology providers, and other service providers.
ICH E6(R3) expressly permits sponsor activities to be transferred, but the sponsor retains overall responsibility for its respective activities and should maintain appropriate oversight. Agreements should define transferred activities and responsibilities clearly.
The UK Policy Framework takes a similar position for contract research organizations: sponsor activities can be delegated, but ultimate responsibility for matters such as research quality and data integrity remains with the sponsor under that framework.
Delegating sponsor activities
Another qualified party performs defined activities under documented arrangements and appropriate sponsor oversight.
Transferring sponsorship
The formally responsible sponsor role itself changes according to the applicable governance or regulatory process.
Hiring a service provider is therefore not automatically the same as transferring sponsorship.
The sponsor should ensure appropriate financial and indemnity arrangements
Sponsorship is not identical to funding, but sponsors still need to consider whether the study has viable financial and liability arrangements.
The UK Policy Framework assigns sponsors responsibility for ensuring adequate finance and management arrangements and appropriate insurance or indemnity for liabilities that may arise in relation to the design, management, and conduct of the research.
The sponsor does not necessarily provide the research grant. It may instead verify that appropriate financial arrangements exist.
This distinction becomes clearer when separating the sponsor from the funder.
The sponsor has responsibilities throughout the project, not only before it begins
Sponsor oversight extends beyond study setup.
Depending on the applicable framework, sponsor responsibilities can include oversight of amendments, safety information, protocol deviations, monitoring findings, data quality, emerging evidence, site performance, regulatory reporting, progress reporting, and decisions about suspension or termination.
The sponsor should also ensure that appropriate arrangements exist for study reporting, dissemination, records, and closure.
Research can change while it is underway. Sponsorship therefore requires continuing oversight rather than a one-time assessment at project launch.
The sponsor and principal investigator have different responsibilities
| Area |
Sponsor |
Principal or Lead Investigator |
| Overall governance arrangements |
Ensures appropriate arrangements exist within the sponsor's remit |
Works within those arrangements and leads research conduct within the investigator's remit |
| Study design and feasibility |
Ensures suitable processes establish that the project is appropriately designed and feasible |
Contributes scientific expertise and is responsible for investigator-level judgments and conduct |
| Team |
Ensures investigators, teams, and sites are suitable where the framework assigns this responsibility |
Leads and appropriately supervises the research team within the investigator's remit |
| Approvals |
Ensures required approvals and arrangements are in place before authorizing commencement where applicable |
Ensures research activities are conducted within the applicable approvals and conditions |
| Oversight |
Maintains proportionate project-level sponsor oversight |
Maintains appropriate investigator-level oversight of research conduct and delegated activities |
| Delegation |
May transfer appropriate sponsor activities while retaining responsibilities assigned by the applicable framework |
May delegate appropriate research activities while retaining investigator oversight responsibilities |
The division is necessarily simplified because terminology and responsibilities vary. The point is that sponsor oversight does not eliminate the principal investigator's responsibilities, just as investigator leadership does not make sponsorship redundant.
The sponsor may also be the institution or funder
One organization can hold several roles.
In non-commercial UK health and social care research, the chief investigator's employer is normally expected to act as sponsor. In commercial research, the funder is commonly the sponsor. The UK Policy Framework nevertheless states explicitly that an employer or funder is not automatically the sponsor. The sponsor responsibilities must be accepted.
Similarly, ICH E6(R3) permits an individual, company, institution, or organization to act as sponsor of a clinical trial, subject to applicable regulatory requirements.
When one organization holds several roles, governance documentation should distinguish the responsibilities attached to each role rather than assuming they merge into a single undefined responsibility.
More than one organization can share sponsorship
Some research systems permit co-sponsorship or joint sponsorship.
Current Health Research Authority guidance states that two or more organizations may act as co-sponsors or joint sponsors. Co-sponsors allocate specified sponsor responsibilities between them, while joint sponsors each accept liability for all sponsor responsibilities under that framework.
ICH E6(R3) also recognizes that clinical trials may have one or several sponsors where permitted by applicable regulatory requirements. Responsibilities should be documented, and where an agreement fails to allocate a sponsor responsibility, that responsibility may remain with all sponsors under the guideline.
This makes written allocation especially important when several institutions share responsibility for one project.
Watch Out
Do not identify an organization as the research sponsor merely because it funds the study, employs the PI, provides the research site, or appears on the ethics application. Determine whether it has formally accepted the sponsor role under the applicable research or regulatory framework.
